CDSCO Registration for Disposable Syringes in India: Class B Licence, IS 10258 and Process

Single-use hypodermic syringes are one of the highest-volume medical devices made and imported in India, and they were among the first to be notified for regulation. Because a syringe is sterile and penetrates the skin, it is not a low-risk commodity in CDSCO’s eyes — it is a Class B device with a defined Indian Standard, sterilisation validation and a proper quality system behind it. This guide sets out the full CDSCO pathway for disposable syringes under the Medical Devices Rules, 2017: classification, the licence you need, IS 10258 and ISO 7886, the documents, the fees and the timeline. This guide explains CDSCO registration for disposable syringes in India — risk class, licence forms, standards, documents, fees and timeline.

Is a CDSCO Registration Mandatory for Disposable Syringes?

Yes. A disposable hypodermic syringe is a notified Class B medical device, and it cannot be manufactured, imported or sold in India without a CDSCO licence. A domestic manufacturer needs a Form MD-5 licence from the State Licensing Authority. An importer needs a Form MD-15 import licence held through an Indian Authorised Agent. Auto-disable and safety syringes fall in the same framework, with their safety feature evidenced in the dossier.

Risk Classification of Disposable Syringes

Every medical device in India falls into one of four risk classes (A, B, C, D) under the First Schedule of the Medical Devices Rules, 2017. The class fixes the authority, the form, the fee, the audit route and the timeline.

Disposable syringes are classified as Class B (low-to-moderate risk). A syringe is a surgically invasive device for transient use that delivers into the body, which places it in Class B under the First Schedule. Where a device could fall in two classes the higher class applies, and an accessory is classified in its own right. Always confirm against the current CDSCO classification list.

Which CDSCO Licence You Need for Disposable Syringes

  • To manufacture disposable syringes in India (Class B) — apply in Form MD-3 to the State Licensing Authority (SLA). The licensing authority grants the licence in Form MD-5. A CDSCO-empanelled Notified Body audits the site. For Class A the audit is post-grant. For Class B the Notified Body conducts it before the licensing authority grants the licence.
  • To import disposable syringes (any class) — the overseas manufacturer appoints an Indian Authorised Agent who files Form MD-14 with the Central Licensing Authority; CDSCO grants the import licence in Form MD-15.
  • Test licence — for a small quantity imported or made for testing, evaluation, demonstration or clinical investigation: Form MD-12 application, Form MD-13 licence.
  • Loan licence — using another licensee’s approved premises: Form MD-4 (Class A/B) or Form MD-8 (Class C/D) for a licence in Form MD-6 or MD-10.

Applicable Standards for Disposable Syringes

Syringes have a clear Indian Standard, and CDSCO expects conformity to it alongside the sterilisation and biocompatibility standards:

  • IS 10258 — sterile hypodermic syringes for single use (dimensions, dead space, graduation accuracy, leakage and performance).
  • ISO 7886-1 — sterile hypodermic syringes for single use (the international equivalent, often cited for imports).
  • IS/ISO 7864 — where the syringe is supplied with a sterile hypodermic needle.
  • ISO 11135 / 11137 — validation of ethylene-oxide or radiation sterilisation.
  • ISO 10993 series — biocompatibility of the fluid path and materials.
  • ISO 594 / ISO 80369 — luer / small-bore connector conformity to prevent misconnection.

Documents Required for CDSCO Registration of Disposable Syringes

Whether you file for a manufacturing or an import licence, CDSCO expects the same core technical dossier built around the device:

  • Covering letter and application form — Form MD-3 (manufacture) or Form MD-14 (import) on the CDSCO Medical Device Online (SUGAM) portal, stating every device, variant and site.
  • Device Master File (DMF) — device description and intended use, materials, design and manufacturing information, ISO 14971 risk file, verification/validation data, sterilisation validation where applicable, shelf-life/stability data and the Essential Principles checklist.
  • Plant Master File (PMF) — site layout, equipment, utilities/HVAC, organisation chart with competent technical staff and the QMS procedures governing production.
  • ISO 13485 QMS certificate — current, with a scope covering the device.
  • Essential Principles of Safety and Performance — a completed checklist mapping the device against each applicable principle with the standard/evidence relied on.
  • Risk management file (ISO 14971) — hazards, risk controls and residual-risk justification.
  • Test / performance reports — against the applicable BIS/IS or ISO/IEC standards from an accredited laboratory.
  • Labels, IFU and packaging — meeting the labelling requirements of the Medical Devices Rules (manufacturer, licence number, sterile status, single-use symbols).
  • Undertaking and declaration of conformity to the Essential Principles and applicable standards.
  • Government fee receipt — paid online through the CDSCO portal.

Device-Specific Documents for Disposable Syringes

Device-specific documents on top of the core set for disposable syringes:

  • IS 10258 / ISO 7886 test reports — graduation accuracy, dead space, leakage, force and performance from an accredited lab.
  • Sterilisation validation — EO residuals or radiation dose, with the sterility assurance level (SAL 10⁻⁶).
  • Biocompatibility reports for the barrel, plunger and lubricant.
  • Shelf-life / stability data supporting the expiry and pack integrity.
  • Needle evidence where a needle is co-packed (IS/ISO 7864, sharpness, bond strength).
  • Safety-feature validation for auto-disable or retractable syringes, if applicable.

For an import licence (Form MD-14) there are three further essentials:

  • Free Sale Certificate (FSC) — from the National Regulatory Authority of the country of origin, legalised (apostille/embassy attestation).
  • Country-of-origin regulatory approval — US FDA 510(k)/PMA, EU CE certificate or equivalent.
  • Power of Attorney and Authorised Agent licence — notarised, legalised PoA to the Indian Authorised Agent, plus the agent’s valid wholesale/manufacturing licence.

QMS & Essential Principles — What CDSCO Checks

  • Essential Principles of Safety and Performance (Fifth Schedule) — the device must be safe and perform as intended, with risks reduced as far as possible. Shown through recognised standards and the risk-management file.
  • Quality Management System (ISO 13485) — design controls, supplier control, process validation, traceability, complaint handling and CAPA, evidenced at audit.
  • Risk management (ISO 14971) — a living file with residual risks justified and communicated in the IFU.
  • Clinical evidence — proportionate to the class: clinical evaluation for lower-risk devices and clinical investigation data for many Class C/D and novel devices.

Label & IFU Requirements Specific to Disposable Syringes

Syringe labelling is checked for sterility and single-use messaging in particular. Labels and IFU must show:

  • Nominal capacity (mL), device name and reference number.
  • Manufacturer name and address, and the CDSCO licence number.
  • Batch/lot number, date of manufacture and use-by (expiry) date.
  • “STERILE” with the sterilisation-method symbol and SAL statement.
  • A clear single-use / do-not-reuse symbol.
  • Storage conditions and “do not use if package is damaged”.

Plain, Safety or Pre-Fillable: Confirm the Variant Scope

A syringe licence is only as wide as the variants you declare. A plain single-use syringe, an auto-disable (AD) immunisation syringe, a retractable safety syringe and a pre-fillable (glass or COP) syringe are different products with different evidence needs, even though they share IS 10258 as a base. Decide upfront which variants and capacities you are registering, because adding a materially different variant later means fresh test data and a licence endorsement — it is not a paperwork tweak.

Step-by-Step CDSCO Registration Process for Disposable Syringes

  1. Confirm the classification. Fix the risk class against the CDSCO classification list and the First Schedule — Class B here — which decides the form, authority, fee and audit route.
  2. Choose the route. Manufacture (Form MD-3 → MD-5) or import (Form MD-14 → MD-15). Importers appoint an Indian Authorised Agent holding a valid manufacturing or wholesale licence.
  3. Build the Device Master File and Plant Master File. Assemble device description, materials, design and process data, the ISO 14971 risk file, sterilisation/stability data and the site file with the QMS.
  4. Complete the Essential Principles checklist. Map the device against each applicable essential principle and cite the BIS/IS or ISO/IEC standard or test report relied on.
  5. Draw the test and performance reports. Test to the applicable standards at an accredited laboratory. Sterile and measuring devices carry additional validation.
  6. Register and file on the CDSCO Online (SUGAM) portal. Create the account, pay the government fee online and upload the full dossier under the correct form.
  7. Site audit / inspection. A CDSCO-empanelled Notified Body audits the site. For Class A the audit is post-grant. For Class B the Notified Body conducts it before the licensing authority grants the licence.
  8. Respond to queries and receive the licence. Answer the deficiency letter within the stipulated period. On approval the licence issues in Form MD-5 (manufacture) or MD-15 (import).

CDSCO Registration Fees and Timeline for Disposable Syringes

The Second Schedule of the Medical Devices Rules sets the fees, and you pay them online through the CDSCO portal. For manufacture of a Class B device the fee is Rs 5,000 per site plus Rs 500 for each distinct device, paid to the State Licensing Authority (SLA). CDSCO charges import fees under Form MD-15 per site and per device in USD — roughly USD 1,000 per site plus USD 50 per device for lower-risk devices, up to about USD 3,000 per site plus USD 1,500 per device for Class C and D. A test licence (Form MD-13) carries a modest fee. Always confirm the current figure on the CDSCO portal before filing.

A complete Class B manufacturing file typically clears in about three to six months. An import (MD-15) file usually takes six to nine months. Every deficiency letter effectively restarts the clock. Unlike the old registration certificates, an MDR 2017 licence does not expire — it stays valid as long as you pay the retention fee (equal to the licence fee) every five years and meet the conditions of licence.

Common Mistakes That Trigger a CDSCO Query

Because syringes are high-volume and heavily audited, the common query reasons are quality-system and sterility-led:

  • Sterilisation validation missing, out of date, or not matching the actual cycle used.
  • Graduation-accuracy or dead-space results outside IS 10258 limits.
  • ISO 13485 scope that does not cover the specific syringe or site.
  • Co-packed needle with no separate IS/ISO 7864 evidence.
  • Free Sale Certificate scope not covering all capacities/variants on import.

Related Approvals to Plan Alongside CDSCO

  • DGFT Importer-Exporter Code — mandatory for any importer of record before the first consignment.
  • Wholesale / sale licence (Form 20B/21B or Form MD-42) — for stocking and distributing the device. The Indian Authorised Agent for an import licence must already hold one.
  • Legal Metrology (LMPC) registration — importers of pre-packaged devices declare MRP, net quantity, importer details and country of origin on the pack.
  • BIS certification — where the device or its electrical components fall under a mandatory BIS/CRS scheme.

Post-Approval Obligations

  • Print the licence number on the label and keep the Essential Principles conformity current.
  • Operate a Post-Market Surveillance (PMS) system and file the Periodic Safety Update Report (PSUR) on the schedule for the device’s class.
  • Report adverse events and field safety corrective actions through the Materiovigilance Programme of India (MvPI) and to CDSCO within the prescribed timelines.
  • Report any change in device, materials, site, labelling or QMS, and any regulatory action or recall in another country.
  • Retain distribution records for traceability and allow CDSCO to draw samples and inspect the premises.
  • Pay the retention fee every five years to keep the licence in force, and track BIS/ISO standard revisions.

FAQs on CDSCO Registration for Disposable Syringes

What CDSCO class is a disposable syringe?

A single-use hypodermic syringe is Class B. A domestic manufacturer files Form MD-3 for a Form MD-5 licence from the State Licensing Authority. An importer files Form MD-14 for a Form MD-15 licence.

Which standard applies to syringes in India?

IS 10258 is the Indian Standard for sterile single-use hypodermic syringes; ISO 7886-1 is the international equivalent often relied on for imports. Co-packed needles follow IS/ISO 7864.

Is a site audit needed for a syringe manufacturing licence?

Yes — for Class B manufacture a CDSCO-empanelled Notified Body audits the site before the licensing authority grants the MD-5 licence.

Do safety and auto-disable syringes need extra evidence?

Yes. The safety or auto-disable feature must be validated in the dossier, and it should be declared as a distinct variant on the licence.

How long does a syringe CDSCO licence take?

A complete Class B manufacturing (MD-5) file typically clears in about three to six months. An import (MD-15) file usually takes six to nine months.

Does the syringe licence expire?

No. An MDR 2017 licence has perpetual validity, subject to paying the retention fee every five years and meeting the conditions of licence.

Related CDSCO Registration Guides

Need end-to-end help? See our CDSCO registration services, or read these related guides:

Official references: Central Drugs Standard Control Organisation (CDSCO) and the CDSCO MD Online portal.

Why Choose PCN India Global

  • Classification triage — we confirm the correct risk class for your disposable syringes against the current CDSCO list before we draft anything.
  • Route selection — manufacture (MD-3/MD-5) or import (MD-14/MD-15), with the Indian Authorised Agent arrangement handled.
  • Dossier build — Device Master File, Plant Master File, Essential Principles checklist and ISO 13485/ISO 14971 readiness.
  • Standards and testing — the right BIS/IS or ISO/IEC standards mapped and accredited test reports coordinated.
  • End-to-end SUGAM filing — application, audit support, query response and the licence grant managed for you.
  • Adjacent approvals — DGFT/IEC, LMPC, wholesale/sale licence and BIS coordinated alongside your CDSCO licence.

PCN India Global manages the complete CDSCO process for disposable syringes — from classification and route selection to Device and Plant Master File preparation, SUGAM filing, audit support and the licence grant. WhatsApp or call +91 80109 05029, or email bdm@pcnindiaglobal.com, to get your registration underway.

Related Compliance Guides

Ashish - PCN Global India Corporation

Ashish

Sitemap: All Certification Services & Guides